107 related articles for article (PubMed ID: 7911271)
1. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
Glasser SP; Bittar N; Labreche DG; Singh B; Katz R; Schulman P
Am J Cardiol; 1994 Jun; 73(16):1165-8. PubMed ID: 7911271
[TBL] [Abstract][Full Text] [Related]
2. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
4. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
5. Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
Glasser SP
Am J Cardiol; 1995 Apr; 75(13):68E-70E. PubMed ID: 7726128
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group.
Frishman WH; Heiman M
Am J Cardiol; 1991 Oct; 68(10):1004-9. PubMed ID: 1927911
[TBL] [Abstract][Full Text] [Related]
7. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium antagonists on exercise tests.
Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
[TBL] [Abstract][Full Text] [Related]
9. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
11. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
13. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
Lam J; Chaitman BR; Crean P; Blum R; Waters DD
J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina.
O'Keefe JC; Creamer JE; Banim SO
Clin Cardiol; 1987 Jun; 10(6):345-50. PubMed ID: 2885117
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
De Caprio L; Papa M; Acanfora D; Abete P; Gallucci F; Covelluzzi F; Cicatiello AM; Rengo F
J Cardiovasc Pharmacol; 1990 Aug; 16(2):325-30. PubMed ID: 1697390
[TBL] [Abstract][Full Text] [Related]
16. Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.
Pedersen TR; Kantor M
Cardiovasc Drugs Ther; 1990 Apr; 4(2):451-6. PubMed ID: 2285629
[TBL] [Abstract][Full Text] [Related]
17. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
18. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia.
Donaldson KM; Dawkins KD; Waller DG
Eur Heart J; 1993 Apr; 14(4):534-9. PubMed ID: 8472719
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
20. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
